Different immunological effects of the molecular targeted agents sunitinib, everolimus and temsirolimus in patients with renal cell carcinomaYukari Kobayashi(University of Tokyo Hospital), Kazuhiro Kakimi(University of Tokyo Hospital)International Journal of OncologyFebruary 4, 202010.3892/ijo.2020.4975Cited by 13SaveCiteExport RISWatch citationsRelated PapersDenatured Mammalian Protein Mixtures Exhibit Unusually High Solubility in Nucleic Acid-Free Pure Water|PLoS ONE|2014|11